BARBATI, Antonella
 Distribuzione geografica
Continente #
EU - Europa 4.670
NA - Nord America 2.680
AS - Asia 1.525
AF - Africa 1.162
SA - Sud America 332
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 10.375
Nazione #
US - Stati Uniti d'America 2.629
IT - Italia 2.626
MA - Marocco 1.143
SG - Singapore 691
UA - Ucraina 514
IE - Irlanda 376
BR - Brasile 269
SE - Svezia 264
CN - Cina 263
HK - Hong Kong 253
RU - Federazione Russa 236
DE - Germania 187
VN - Vietnam 166
FI - Finlandia 143
FR - Francia 77
GB - Regno Unito 77
KR - Corea 46
NL - Olanda 42
CH - Svizzera 32
MX - Messico 29
PL - Polonia 21
PE - Perù 20
TR - Turchia 20
AR - Argentina 19
BE - Belgio 17
ES - Italia 17
IN - India 15
AT - Austria 13
CA - Canada 12
JP - Giappone 11
BD - Bangladesh 9
CL - Cile 7
RO - Romania 7
UZ - Uzbekistan 7
ZA - Sudafrica 7
GR - Grecia 6
KE - Kenya 6
EC - Ecuador 5
IQ - Iraq 5
LB - Libano 5
PK - Pakistan 5
VE - Venezuela 5
GT - Guatemala 4
ID - Indonesia 4
SA - Arabia Saudita 4
CZ - Repubblica Ceca 3
EU - Europa 3
LT - Lituania 3
PH - Filippine 3
PY - Paraguay 3
AU - Australia 2
AZ - Azerbaigian 2
CO - Colombia 2
CY - Cipro 2
DO - Repubblica Dominicana 2
IL - Israele 2
IR - Iran 2
NP - Nepal 2
TN - Tunisia 2
AL - Albania 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EG - Egitto 1
GE - Georgia 1
HN - Honduras 1
IM - Isola di Man 1
JM - Giamaica 1
JO - Giordania 1
KZ - Kazakistan 1
MD - Moldavia 1
MT - Malta 1
MY - Malesia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
SN - Senegal 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 10.375
Città #
Ouezzane 1.142
Chandler 415
Singapore 376
Dublin 375
San Mateo 256
Hong Kong 253
Milan 187
Rome 177
Boardman 137
Des Moines 129
Santa Clara 124
Jacksonville 108
Dong Ket 105
Medford 105
Princeton 105
Ann Arbor 87
Wilmington 81
Ashburn 79
Moscow 78
Naples 75
Beijing 63
Andover 62
Catania 56
Bari 50
Bologna 47
Seoul 45
Florence 44
Perugia 40
Palermo 37
Turin 37
Helsinki 31
São Paulo 26
Ho Chi Minh City 25
New York 25
Padova 25
Saint Petersburg 23
Munich 22
Genoa 21
Brescia 19
Altamura 18
Piscataway 18
Lima 17
Redwood City 17
Woodbridge 17
Los Angeles 15
Falkenstein 14
Hanoi 14
Lawrence 14
Norwalk 14
Shanghai 14
Dallas 13
Dearborn 13
Pescara 13
Brussels 12
Venice 12
Falls Church 11
Jesi 11
Napoli 11
Pisa 11
Salerno 11
Izmir 10
London 10
The Dalles 10
Cagliari 9
Messina 9
San Diego 9
San Francisco 9
Tokyo 9
Trieste 9
Catanzaro 8
Den Haag 8
Livorno 8
Monza 8
Turku 8
Auburn Hills 7
Brasília 7
Chennai 7
Columbus 7
Dalmine 7
Boston 6
Chieti 6
Curitiba 6
Frankfurt Am Main 6
Frankfurt am Main 6
Gavardo 6
Lausanne 6
Nairobi 6
Parma 6
Pavia 6
Pesaro 6
Taranto 6
Tijuana 6
Verona 6
Vienna 6
Warsaw 6
Belo Horizonte 5
Bucharest 5
Campi Bisenzio 5
Campinas 5
Cascina 5
Totale 5.662
Nome #
Fisiopatologia del Cordone Ombelicale. 4.111
An immunoistochemical study of c-erbB-2 oncoprotein in breast cancer. 112
Renal Consequences of Gestational Diabetes Mellitus in Term Neonates: A Multidisciplinary Approach to the DOHaD Perspective in the Prevention and Early Recognition of Neonates of GDM Mothers at Risk of Hypertension and Chronic Renal Diseases in Later Life 109
Antigeni oncofetali in gravidanza. 108
CA 125 in pregnancy 102
Amniotic membrane: separation of amniotic mesoderm from amniotic epithelium and isolation of their respective mesenchymal stromal and epithelial cells. 101
Umbilical cord hematoma with altered fetal heart rate. A case report. 100
Liquido Amniotico: fisiologia e patologia 100
CA 125 and PLAP in maternal blood and amniotic fluid during pregnancy. 98
Biophysical and biochemical methods for early detection of breast tumours 96
Rare immunological presentation in B-cell chronic lymphocytic leukaemia. 96
Analisi dell'oncogene c-erbB-2 nell'adenocarcinoma gastrico mediante FISH. 95
Immunoblotting characterization of CA 125 in biological fluids:difference between pregnancy and cancer CA 125 origin. 94
Markers for breast cancer. 92
Immunochemical and immunohistochemical evaluation of lung permeability in ventilated newborn rabbits 91
Effect of aminophylline on lung maturation in preterm rabbit fetuses 91
Cytotoxicity of universal dental adhesive systems: Assessment in vitro assays on human gingival fibroblasts 90
Lung maturation and prematurity 87
Indagine sulle morti fetali endouterine: incidenza e cause riscontrate nel periodo 1994-2006 86
A common aspect of pregnancy and malignancy: Oncofetal antigens. 82
CA 125 in peritoneal fluid: Reliable values at high dilutions. 81
CA 125 in human fluids:Facts and artifacts. 78
Value of c-erbB-2 and p53 oncoprotein co-overexpression in human breast cancer. 76
Placental alkaline phosphatase as a marker for ovarian cancer. 76
Assessment of fetal lung maturity and prenatal prevention of respiratory distress syndrome. 75
Antigeni oncofetali: loro possibili implicazioni in medicina fetale. 74
VALUATION OF BI OCHEMICAL PARAMETER S OF RENAL IMPAIRMENT/INJURY AND SURROGATE MARKER S OF NEPHRON NUMBER IN IUGR AND PRETERM NEONATES AT 30-40 DAYS OF POSTNATAL CORRECTED AGE 74
Biochemical parameters of renal impairment/injury and surrogate markers of nephron number in intrauterine growth-restricted and preterm neonates at 30–40 days of postnatal corrected age 74
Biochemical markers of endometriosis 72
Analisi critica dei metodi per la valutazione della maturità polmonare fetale. 72
Increased urinary Cystatin-C levels correlate with reduced renal volumes in neonates with intrauterine growth restriction 72
CA 125 and endometriosis 71
Tumor-associated trypsin inhibitor (TATI) in patients with ovarian carcinoma: comparison with CA 125. 68
Indagine sulla frequenza di infezioni da chlamydia in utenti consultoriali in Umbria. 68
Elevated peritoneal fluid levels of CA 125 in patients with endometriosis. 67
The validation of immunoblot SDS-PAGE as a qualitative and quantitative method for the determination of urinary Cystatin C in neonates 67
Intrauterine fetal death incidence in the last ten years. 66
Risk of breast cancer 65
Incidenti del cordone ombelicale 65
Lysosomal glycohydrolases in patients with gynecological cancer. 65
Fetal lung maturity: Diagnostic methods 65
Serum evaluation of p53 protein in gynecological cancer patients. 64
Ontogeny of CA 125 antigen in pregnancy: Immunoradiometric determination in amniotic fluid and immunohistochemical localization in fetal membranes. 62
Evaluation of the second generation CA 125 assays 61
Oncofetal antigens in pregnancy. 61
Aspetti Immunologici della infertilità. Nota IV: ricerca degli anticorpi antispermatozoo mediante la tecnica dell'immunofluorescenza. 61
REDUCED RENAL VOLUMES AND ELEVATED LEVELS OF CYSTATIN-C IN THE URINE OF NEONATES WITH IUGR 60
The measurement of amniotic fluid phosphatidyl glycerol for the assessment of fetal lung maturity. 59
Monoclonal antibodies and the trophoblast. 58
Hook effect in immunoradiometric assay for CA 125 determination in peritoneal fluid: Evidence of high CA 125 levels by a comparative immunoblotting analysis. 57
Serum Evaluation of p53 Protein in Patients with Gnaecological Cancer. 57
Main clinical analyses on amniotic fluid. 57
The trophoblast and monoclonal antibodies. 57
Regulation of CA125 Production by amnion cells in culture. 57
Livelli di CA 125 nel siero e nel liquido peritoneale di pazienti con endometriosi. 57
Sviluppo e profilo biochimico del surfattante polmonare 56
Lung permeability of the immature and nearterm fetal rabbit: Immunochemical and immunohistochemical studies 56
Lo sviluppo morfologico del polmone fetale. 56
Biophysical and Biochemical Methods for early Detection of Breast Tumors. 55
QF-PCR and MLPA: a reliable molecular system to detect chromosomal alterations in miscarriages 55
Analisi critica dei markers tumorali nella diagnosi del carcinoma ovarico. 54
Identification of c-erbB-2 oncoprotein in serum: Elevated levels in breast cancer patients. 54
Serum and peritoneal fluid CA-125 levels in patients with endometriosis. 53
Regulation of CA 125 production by amnion and Wish cell in culture. 53
Bronchial washing as a model of R.D.S. in the adult. 53
Hot-flashes in Breast Cancer Survivors: Effectiveness of Low-dosage Fluoxetine. A Pilot Study 52
HER-2 Amplification in Gastric Cancer Detected by Fluorescence in situ Hybridization. 52
Determination of CA 125 in peritoneal fluid: Reliable values at high dilutions. 51
Placental alkaline phosphatase in ovarian and other tumours 51
CA125 antigen levels in peritoneal fluid of gynecologic patients. 51
Evidence of oncogene products in gynecological cancer patients 51
Serum quantification of HER-2/neu oncoprotein in gynecological patients. 51
Endocrinologia in Gravidanza. A) Modificazioni dell’assetto endocrino materno 51
Monoclonal antibodies and their application in gestational trophoblastic neoplasia 51
No evidence of the hook effect in peritoneal fluid CA 125 measurement using immunoenzymatic second generation assays: comparison with immunoradiometric assays. 50
The use of aminophylline for the treatment of preterm labor. 50
Marcatori tumorali umorali 48
Glucocorticoids and inositol interactions on fetal rabbit lung maturation. 48
Effect of aminophylline on lung maturation in preterm rabbit fetuses. 47
Effects of aminophylline on uterine activity 46
Immunohistochemical localization of CA 125 antigen in fetal membranes and placental tissue during gestation. 46
Regulation of CA125 production by amnion and Wish cells in culture 46
Produzione di anticorpi monoclonali verso il sinciziotrofoblasto. 45
La placenta e il liquido amniotico 44
CA125 is released by human amnion cells in culture 44
Elevated erbB-2 oncoprotein levels in serum of patients with breast cancer. 43
Inositol and glucocorticoid in the development of lung stability in male and female rabbit fetuses 43
Diagnosi e trattamento dell'immaturità polmonare. 43
Validità diagnostica dell'associazione di markers tumorali nel carcinoma ovarico. 43
Fisiologia funzionale feto-placentare. 43
Screening ultrasonografico per la ricerca delle neoplasie ovariche ed endometriali in pazienti con età>45 anni: risultati preliminari 43
Studi sull'ontogenesi del marker oncofetale CA 125. 41
Ruolo dei Marcatori Umorali nell'Endometriosi 40
Valutazione del TATI come marker tumorale nella patologia oncologica. 40
Clinical value of serum c-erbB-2 vis-a-vis 3D echography in patients with breast cancer. 39
p53 and HER-2 protein co-overexpression in human breast cancer 38
PLAP, TATI and CA 125 in ovarian cancer. 38
Evaluation of IRMA-II and ETI-II assay in serum and peritoneal fluid CA 125 determination 37
Identificazione del marker tumorale CA 125 nel liquido seminale. 36
Complete responce with paclitaxel (taxol) in metastatic breast cancer during pregnancy. 35
Totale 10.382
Categoria #
all - tutte 34.713
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.713


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021505 0 0 0 0 0 93 68 12 105 39 62 126
2021/2022945 25 154 35 42 31 18 17 292 13 39 90 189
2022/20232.683 144 106 46 107 114 277 1.151 84 539 18 69 28
2023/2024809 57 77 37 56 47 21 101 49 65 67 104 128
2024/20252.047 78 205 190 104 183 110 97 185 351 142 290 112
2025/20261.273 196 167 133 370 349 58 0 0 0 0 0 0
Totale 10.541